CN104557935B - Preparation (R)-8-(3-amino piperidine-1-base)-xanthic method of purification - Google Patents

Preparation (R)-8-(3-amino piperidine-1-base)-xanthic method of purification Download PDF

Info

Publication number
CN104557935B
CN104557935B CN201510041466.0A CN201510041466A CN104557935B CN 104557935 B CN104557935 B CN 104557935B CN 201510041466 A CN201510041466 A CN 201510041466A CN 104557935 B CN104557935 B CN 104557935B
Authority
CN
China
Prior art keywords
base
amino piperidine
xanthine
hour
purification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510041466.0A
Other languages
Chinese (zh)
Other versions
CN104557935A (en
Inventor
黄乐群
王磊
郭露粉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JIANGSU YIJIA PHARMACEUTICAL Co Ltd
Original Assignee
JIANGSU YIJIA PHARMACEUTICAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JIANGSU YIJIA PHARMACEUTICAL Co Ltd filed Critical JIANGSU YIJIA PHARMACEUTICAL Co Ltd
Priority to CN201510041466.0A priority Critical patent/CN104557935B/en
Publication of CN104557935A publication Critical patent/CN104557935A/en
Application granted granted Critical
Publication of CN104557935B publication Critical patent/CN104557935B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms

Abstract

The invention discloses one and prepare (R) 8 (3 amino piperidine 1 base) xanthic method of purification, comprise the steps: that 8 (3 amino piperidine 1 base) the xanthine crude product obtained carries out into salt with suitable acid reaction to be purified, making beating, then obtain highly purified (R) 8 (3 amino piperidine 1 base) xanthine with the neutralization of suitable alkali.Product not only productivity obtained by the method for purification that the present invention provides is higher and operation is simpler, and the time, shorter being conducive to was commercially produced, and most importantly product purity is higher, and products obtained therefrom can guarantee that in API that all lists are miscellaneous and is held at 0.1% level below.

Description

Preparation (R)-8-(3-amino piperidine-1-base)-xanthic method of purification
Technical field
Present invention relates particularly to one and prepare (R)-8-(3-amino piperidine-1-base)-xanthic method of purification.
Background technology
Patent WO 04/018468 discloses a kind of 8-(3-amino piperidine-1-base)-xanthine and utilizes tertbutyloxycarbonyl Prepared by the derivant deprotection of protection, and tertbutyloxycarbonyl protection group is made into by patent CN101048409A Use phthalic acid anhydride group.
But this patent has simply focused on the improvement on route, and is not absorbed in the improvement of method of purification, it purifies Method has to pass through twice recrystallization and operation complexity, and purification time is long, is not suitable for industrialized great production equipment Operation.And (R)-8-obtained (3-amino piperidine-1-base) is although-xanthine meets drug registration requirement at that time, But along with people drug safety is required more and more higher, during drug registration prescription the strictest For under background, (R)-8-(3-amino piperidine-1-the base)-xanthine using this method of purification to obtain can not meet to be wanted Ask, still its method of purification is improved.
Summary of the invention
Goal of the invention: the present invention provides one to prepare (R)-8-(3-amino piperidine-1-base)-xanthic method of purification.
Technical scheme: one prepares (R)-8-(3-amino piperidine-1-base)-xanthic method of purification, including as follows Step: 8-(3-amino piperidine-1-the base)-xanthine crude product obtained is carried out into suitable acid reaction salt and purifies, Making beating, then obtain highly purified (R)-8-(3-amino piperidine-1-base)-xanthine with the neutralization of suitable alkali.
As optimization: described acid is: hydrochloric acid, hydrobromic acid, benzenesulfonic acid, benzoic acid, glycolic, malonic acid, Pyroglutamic acid, salicylic acid, maleic acid, oxalic acid, benzoic acid, citric acid, L-TARTARIC ACID and D-tartaric acid.
As preferably, described acid is hydrochloric acid, maleic acid, D-tartaric acid.
As optimization: in described salification process organic solvent mainly select methanol, ethanol, normal propyl alcohol, isopropanol, One or more in ethyl acetate, dichloromethane, acetone;Reaction temperature selects 20-80 DEG C.
As optimization: described organic solvent preferred alcohol;Reaction temperature is preferably 70-80 DEG C.
As optimization: in described pulping process, organic solvent is: methanol, ethanol, ethyl acetate, dichloromethane, One or more in acetone;Making beating temperature is 20-80 DEG C.
As optimization: organic solvent preferred alcohol in described pulping process, or, ethanol: ethyl acetate=1:1; Making beating temperature is preferably 70-80 DEG C.
As optimization: in described N-process, solvent has: the one or several in water, methanol, ethanol and acetone etc. Kind;Reaction temperature-10-50 DEG C;Alkali is: sodium bicarbonate, potassium carbonate, sodium carbonate, sodium hydroxide, triethylamine, One or more in N, N-diisopropylethylamine.
As preferably, in described N-process, solvent is water;Reaction temperature 5-10 DEG C;Alkali is: triethylamine and N, N-diisopropylethylamine.
As optimization: preparation (R)-8-(3-amino piperidine-1-base)-xanthic method of purification:
A. salt-forming reaction pulling an oar:
Synthesis is obtained (R)-8-(3-amino piperidine-1-base)-xanthine 1kg, ethanol 18kg and adds 50L reactor In, be back to molten clearly, by D-(-)-tartaric acid 0.32kg be dissolved in 2.5kg ethanol stir molten clear after, be added dropwise to In above-mentioned reactant liquor, within one hour, drip off, back flow reaction 1 hour, close heating and naturally cool to room temperature, mistake Filter, 500ml ethanol rinse;Filter cake is transferred in 50L reactor, addition methanol 8kg, ethyl acetate 8kg, Backflow making beating 1 hour, is cooled to 30 DEG C, filters, filter cake 60 DEG C of drying under reduced pressure 12 hours, obtain white extremely Faint yellow solid;
B. in and reaction:
Upper step gained (R)-8-(3-amino piperidine-1-base)-xanthine tartrate 1.12kg is added 50L reactor In, add water 30L, is cooled to 5-10 DEG C after stirring and dissolving, and dropping triethylamine 0.65kg drips off for mono-hour, surveys About pH=10, add methylene chloride 10L, extraction, and aqueous phase extracts with dichloromethane 5L again, merges organic facies, It is evaporated to 2L, methylate tertbutyl ether 3L, is concentrated into 2L, methylate tertbutyl ether 5L, backflow 1 Hour, naturally cooling to room temperature, filter, filter cake, 60 DEG C of drying under reduced pressure 12 hours, obtains white to faint yellow Solid.
Beneficial effect: the product not only productivity obtained by the method for purification that the present invention provides is higher and operation is simpler Single, the time, shorter being conducive to was commercially produced, and most importantly product purity is higher, and products obtained therefrom can guarantee that In API, all lists are miscellaneous is held at 0.1% level below.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention will be described in detail.
Summary:
One prepares (R)-8-(3-amino piperidine-1-base)-xanthic method of purification, and comprising the steps: must To 8-(3-amino piperidine-1-base)-xanthine crude product carry out into salt with suitable acid reaction and purify, making beating, then with Suitably alkali neutralizes and obtains highly purified (R)-8-(3-amino piperidine-1-base)-xanthine.
Described acid is: hydrochloric acid, hydrobromic acid, benzenesulfonic acid, benzoic acid, glycolic, malonic acid, pyroglutamic acid, Salicylic acid, maleic acid, oxalic acid, benzoic acid, citric acid, L-TARTARIC ACID and D-tartaric acid.As preferably, Described acid is hydrochloric acid, maleic acid, D-tartaric acid.
In described salification process organic solvent mainly select methanol, ethanol, normal propyl alcohol, isopropanol, ethyl acetate, One or more in dichloromethane, acetone;Reaction temperature selects 20-80 DEG C.As optimization: described organic Solvent preferred alcohol;Reaction temperature is preferably 70-80 DEG C.
In described pulping process, organic solvent is: in methanol, ethanol, ethyl acetate, dichloromethane, acetone One or more;Making beating temperature is 20-80 DEG C.As optimization: the preferred second of organic solvent in described pulping process Alcohol, or, ethanol: ethyl acetate=1:1;Making beating temperature is preferably 70-80 DEG C.
In described N-process, solvent has: one or more in water, methanol, ethanol and acetone etc.;Reaction temperature Spend-10-50 DEG C;Alkali is: sodium bicarbonate, potassium carbonate, sodium carbonate, sodium hydroxide, triethylamine, N, and N-bis-is different One or more in propylethylamine.
As preferably, in described N-process, solvent is water;Reaction temperature 5-10 DEG C;Alkali is: triethylamine and N, N- Diisopropylethylamine.
Specific embodiment:
Preparation (R)-8-(3-amino piperidine-1-base)-xanthic method of purification:
A. salt-forming reaction pulling an oar:
Synthesis is obtained (R)-8-(3-amino piperidine-1-base)-xanthine 1kg, ethanol 18kg and adds 50L reactor In, be back to molten clearly, by D-(-)-tartaric acid 0.32kg be dissolved in 2.5kg ethanol stir molten clear after, be added dropwise to In above-mentioned reactant liquor, within one hour, drip off, back flow reaction 1 hour, close heating and naturally cool to room temperature, mistake Filter, 500ml ethanol rinse;Filter cake is transferred in 50L reactor, addition methanol 8kg, ethyl acetate 8kg, Backflow making beating 1 hour, is cooled to 30 DEG C, filters, filter cake 60 DEG C of drying under reduced pressure 12 hours, obtain white extremely Faint yellow solid;
B. in and reaction:
Upper step gained (R)-8-(3-amino piperidine-1-base)-xanthine tartrate 1.12kg is added 50L reactor In, add water 30L, is cooled to 5-10 DEG C after stirring and dissolving, and dropping triethylamine 0.65kg drips off for mono-hour, surveys About pH=10, add methylene chloride 10L, extraction, and aqueous phase extracts with dichloromethane 5L again, merges organic facies, It is evaporated to 2L, methylate tertbutyl ether 3L, is concentrated into 2L, methylate tertbutyl ether 5L, backflow 1 Hour, naturally cooling to room temperature, filter, filter cake, 60 DEG C of drying under reduced pressure 12 hours, obtains white to faint yellow Solid.
Product not only productivity obtained by the method for purification that the present invention provides is higher and operation is simpler, and the time is shorter Being conducive to commercially producing, most importantly product purity is higher, and products obtained therefrom can guarantee that all lists in API Miscellaneous it is held at 0.1% level below.

Claims (1)

1. prepare (R)-8-(3-amino piperidine-1-base)-xanthic method of purification, its feature It is: comprise the steps: 8-(3-amino piperidine-1-the base)-xanthine crude product that will obtain Carry out into salt to purify with suitable acid reaction, making beating, then obtain with the neutralization of suitable alkali (R)-8-(3-amino piperidine-1-base)-xanthine;
Concrete operations are as follows:
A. salt-forming reaction pulling an oar:
Synthesis obtains (R)-8-(3-amino piperidine-1-base)-xanthine 1kg, and ethanol 18kg adds Enter in 50L reactor, be back to molten clearly, by D-(-)-tartaric acid 0.32kg is dissolved in 2.5kg ethanol stirs molten clear after, be added dropwise in above-mentioned reactant liquor, within one hour, drip off, return Stream reaction 1 hour, closes heating and naturally cools to room temperature, filter, 500ml ethanol rinse; Filter cake is transferred in 50L reactor, adds methanol 8kg, ethyl acetate 8kg, backflow Pull an oar 1 hour, be cooled to 30 DEG C, filter, filter cake 60 DEG C of drying under reduced pressure 12 hours, Obtain white to faint yellow solid;
B. in and reaction:
Upper step gained (R)-8-(3-amino piperidine-1-base)-xanthine tartrate 1.12kg is added In 50L reactor, add water 30L, is cooled to 5-10 DEG C after stirring and dissolving, drips triethylamine 0.65kg drips off for mono-hour, surveys pH=10, and add methylene chloride 10L, and extraction, aqueous phase is used again Dichloromethane 5L extracts, and merges organic facies, is evaporated to 2L, methylate tertbutyl ether 3L, It is concentrated into 2L, methylate tertbutyl ether 5L, refluxes 1 hour, naturally cool to room temperature, Filtering, filter cake, 60 DEG C of drying under reduced pressure 12 hours, obtains white to faint yellow solid.
CN201510041466.0A 2015-01-27 2015-01-27 Preparation (R)-8-(3-amino piperidine-1-base)-xanthic method of purification Active CN104557935B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510041466.0A CN104557935B (en) 2015-01-27 2015-01-27 Preparation (R)-8-(3-amino piperidine-1-base)-xanthic method of purification

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510041466.0A CN104557935B (en) 2015-01-27 2015-01-27 Preparation (R)-8-(3-amino piperidine-1-base)-xanthic method of purification

Publications (2)

Publication Number Publication Date
CN104557935A CN104557935A (en) 2015-04-29
CN104557935B true CN104557935B (en) 2016-08-17

Family

ID=53075101

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510041466.0A Active CN104557935B (en) 2015-01-27 2015-01-27 Preparation (R)-8-(3-amino piperidine-1-base)-xanthic method of purification

Country Status (1)

Country Link
CN (1) CN104557935B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101150449B1 (en) * 2002-08-21 2012-06-01 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 8-3---1-- 8-[3-Amino-piperidin-1-yl]-xanthines the production thereof and the pharmaceutical composition containing the same
DE102004054054A1 (en) * 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process for preparing chiral 8- (3-amino-piperidin-1-yl) -xanthines

Also Published As

Publication number Publication date
CN104557935A (en) 2015-04-29

Similar Documents

Publication Publication Date Title
CN103980275B (en) The preparation method of PDE5 inhibitor tadanafil
CN108129288B (en) Synthesis method of trans-3-hydroxycyclobutylformic acid
CN105732765B (en) The novel synthesis of hepatitis drug Wei Patawei
CN103435538B (en) (R) preparation method of-3-amido piperidine hydrochlorate
JP2018537510A (en) Process for producing 1,3-benzodioxole heterocyclic compound
CN105541573B (en) A kind of method for preparing the alkene dialdehyde of 2,6,11,15 tetramethyl, 2,4,6,8,10,12,140 six carbon seven
CN103509025A (en) Preparation method of epinastine hydrochloride and intermediate thereof
CN107721999A (en) A kind of preparation method of the quinuclidinol of optical activity 3
CN106366076B (en) A kind of synthetic method of posaconazole
CN102367236A (en) Synthesizing technology of donepezil hydrochloride
CN104557935B (en) Preparation (R)-8-(3-amino piperidine-1-base)-xanthic method of purification
CN103787975A (en) Huperzine A D-dibenzoyltartartrate and preparation method and application thereof
CN104130288A (en) Tenofovir disoproxil salt preparation method
CN107400154A (en) One kind prepares 3 α, the method for the 7 α-α of bis-hydroxy-6-β of ethyl-5-cholanic acid
CN107721849A (en) A kind of method for preparing amide of mint intermediate peppermint acid
CN106810554A (en) A kind of preparation method of Tadalafei compound
MX2013014247A (en) Novel process for the synthesis of 7-chloro-4-(piperazin-1-yl)-qu inoline.
CN104974051A (en) Synthetic method for (1S,4R)-cis-4-amino-2-cyclopentene-1-methanol hydrochloride
CN101781305A (en) Method for artificially synthesizing galanthamine
CN106336411B (en) The preparation technology and purposes of CDK4/6 inhibitor Pa Boxini high-purity raw medicines
CN102786543A (en) Preparation methods for imidazole[1,2-a]pyridine-6-boric acid pinacol ester and derivatives thereof
CN107488176B (en) Method for synthesizing famciclovir impurity C
CN103086956A (en) Purification method of clevidipine butyrate intermediate
CN103435591B (en) Chemical synthesis method of piperine
CN108727214A (en) A kind of synthetic method of anesthetic bupivacaine impurity

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant